—

Globus Medical (GMED) — Technical state

As of 2026-11-13 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.

The Closelooknet read

  • Closelooknet score: 60 out of 100 (momentum 29 · quality 66 · valuation 57), as of 2026-11-17.
  • Signal: Resizing — 28.9% off its high — 28.9% below its 52-week high, under its 200-day — a deeper resizing of the trend, not a shallow dip. (as of 2026-11-13)
  • Trend: Globus Medical trades 5.8% below its 50-day and 12.8% below its 200-day moving average. (as of 2026-11-13)
  • Index seat: HALO Growth 100

Globus Medical makes implants and instruments for spine, orthopaedic trauma and hip-and-knee surgery, treating musculoskeletal disorders. It also builds the ExcelsiusGPS robotic guidance platform and related navigation and neuromonitoring tools used during procedures.

The full read — the desk's view, the earnings record, peers and the company snapshot — is on the GMED overview. Agents can buy the score depth per call over HTTP 402 — see the catalogue. Research diary readings, not advice.

Resizing — 28.9% off its high

28.9% below its 52-week high, under its 200-day — a deeper resizing of the trend, not a shallow dip.

The moving-average stack

FAQ · from the current data · as of 2026-11-13

Quick answers

What is the current Closelooknet signal on GMED?

Resizing — 28.9% off its high — 28.9% below its 52-week high, under its 200-day — a deeper resizing of the trend, not a shallow dip. As of 2026-11-13; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.

Is GMED above its 50-day and 200-day moving averages?

As of 2026-11-13, Globus Medical trades -5.8% below its 50-day and -12.8% below its 200-day average, with the 20-day -8.2% away.

How far is GMED from its 52-week high?

28.9% below the 52-week high and 27.7% above the 52-week low, as of 2026-11-13.

Related in the Closelooknet universe

same Closelooknet index seat first, then Medical Devices. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.